# Cataract

Manage cataract by confirming that lens opacity—not corneal, retinal, optic nerve, or refractive disease—is the principal functional limitation; then align surgical timing, ocular risk stratification, intraocular lens selection, infection prevention, and follow-up with visual goals and comorbidity.

**Clinical question:** How should physicians evaluate cataract-related visual dysfunction and plan safe, goal-concordant cataract surgery?

Updated: 2026-08-24T16:42:10.818288+00:00

## What matters in practice
- Proceed toward cataract extraction when lens opacity is the principal cause of functionally important visual impairment after slit-lamp examination and assessment of competing ocular pathology. [24]
- For routine low-risk cataract surgery, use patient-specific medical assessment rather than universal laboratory testing or mandatory medical consultation; routine testing has not improved major perioperative outcomes. [1][16]
- Active infection and uncontrolled systemic disease should be treated and stabilized before surgery; record blood pressure and blood glucose as part of individualized perioperative assessment. [15]
- Povidone-iodine 5% reduces eyelid-margin bacterial recovery and is a core preoperative antiseptic measure; evidence summarized in current guidance does not show clear benefit from routine preoperative topical antibiotics. [9][10]
- In Fuchs endothelial corneal dystrophy, distinguish cataract-predominant impairment from corneal edema using history, slit-lamp examination, corneal tomography, specular microscopy, and pachymetry before choosing cataract surgery alone, staged surgery, or combined endothelial keratoplasty and cataract surgery. [23]

## Confirm that cataract is the actionable cause of visual dysfunction

Surgical benefit depends on linking the lens finding to the patient’s functional complaint.

Document monocular visual acuity and perform slit-lamp examination in undilated and dilated pupils to characterize lens opacity and assess whether it plausibly accounts for reduced acuity, glare, halos, photophobia, or reduced contrast function. Cataract diagnosis is clinical; management should be driven by cataract stage, symptoms, age, and the expected contribution of lens extraction to functional vision. [24]

Do not use visual acuity alone as the surgical indication. A patient with disabling glare, night-driving limitation, or contrast loss may have clinically meaningful cataract despite relatively preserved chart acuity, whereas limited postoperative potential should be anticipated when another ocular disorder is the dominant source of impairment. In patients undergoing surgery, corrected distance visual acuity of 20/20 or better after surgery has been associated with more accurate refractive outcome. [13][24]

Before committing to surgery, identify ocular conditions that alter prognosis or procedure selection. In particular, evaluate suspected Fuchs endothelial corneal dystrophy with targeted history, slit-lamp examination, corneal tomography, specular microscopy, and pachymetry; glare and contrast loss overlap with cataract symptoms and are insufficient discriminators by themselves. [23]
- Ask specifically about morning blur that improves during the day, which favors corneal edema from Fuchs endothelial corneal dystrophy over cataract-predominant impairment. [23]
- Ask about foreign-body sensation or pain from epithelial bullae; these findings support clinically consequential corneal disease and may shift planning toward endothelial keratoplasty. [23]
- Note a myopic shift as a lens-related clue when deciding whether cataract is contributing materially to reduced vision. [23]

*Clinical branches when cataract coexists with a potential competing cause of visual loss. [23][24]*

| Clinical pattern | Discriminating evaluation | Next procedural decision |
| --- | --- | --- |
| Lens opacity with symptoms concordant with examination | Monocular acuity plus slit-lamp examination in undilated and dilated pupils support clinical cataract assessment. [24] | Discuss cataract extraction when functional limitation is attributable principally to the cataract. [24] |
| Fuchs endothelial corneal dystrophy with cataract | Morning blur that improves with corneal deturgescence, bullae-related discomfort, slit-lamp findings, tomography, specular microscopy, and pachymetry help determine the relative contribution of cornea and lens. [23] | Select cataract surgery alone, sequential surgery, or combined endothelial keratoplasty with cataract surgery according to corneal versus lenticular contribution and patient preference. [23] |
| Uncertain visual potential from coexisting ocular disease | Use history, examination, and targeted diagnostic testing to identify the structure limiting vision before assigning expected benefit to lens surgery. [23][24] | Counsel on guarded visual outcome and address the competing ocular pathology before or alongside cataract planning. [23][24] |

## Select surgery and intraocular lens strategy around visual goals and ocular anatomy

Cataract surgery with intraocular lens implantation is the definitive intervention for visually significant lens opacity. [20]

Use the preoperative visit to establish the desired refractive target, tolerance for spectacles, and need for astigmatism correction, then reconcile those goals with corneal status and the expected quality of vision. Presbyopia-correcting and toric intraocular lens strategies are available, but selection should be individualized because coexisting corneal disease can reduce the predictability or quality of a premium-lens outcome. [3][4][23]

For Fuchs endothelial corneal dystrophy, the pivotal decision is whether cataract surgery alone is likely to meet the visual goal without precipitating or leaving clinically significant endothelial failure. DMEK, replacing diseased endothelium and Descemet membrane with donor tissue, is the established therapeutic option for clinically significant Fuchs disease; cataract extraction and DMEK may be performed alone, in combination, or sequentially after assessment of corneal and lenticular contributions. [23]

Consider femtosecond laser-assisted cataract surgery as a technical option rather than a presumed universal outcome advantage. Compared with conventional phacoemulsification, femtosecond assistance can create more precise capsulotomies and reduce ultrasound energy; its astigmatic keratotomy application has evidence for low-to-moderate astigmatism below 1.5 diopters. [12]
- Use corneal tomography, specular microscopy, and pachymetry before choosing a presbyopia-correcting lens in Fuchs endothelial corneal dystrophy. [23]
- Explain that manual capsulorhexis errors in size or centration can contribute to intraocular lens tilt or decentration and unsatisfactory visual outcomes; femtosecond capsulotomy offers greater precision and consistency. [12]
- When treating low-to-moderate astigmatism below 1.5 diopters with femtosecond astigmatic keratotomy, discuss the procedure-specific tradeoff against manual limbal relaxing incisions, including manual-incision reproducibility and wound-related complications. [12]

*Procedure-selection considerations for common cataract planning scenarios. [3][4][12][23]*

| Scenario | Useful planning data | Decision consequence |
| --- | --- | --- |
| Desire for reduced spectacle dependence | Refractive target, corneal assessment, and patient tolerance for optical tradeoffs should be documented before selecting a presbyopia-correcting intraocular lens. [3][4] | Consider a presbyopia-correcting intraocular lens only when ocular status and visual goals support it. [3][4][23] |
| Low-to-moderate astigmatism | Magnitude below 1.5 diopters is the range described for femtosecond astigmatic keratotomy efficacy. [12] | Femtosecond astigmatic keratotomy is an available correction strategy; compare it with other refractive planning options. [12] |
| Fuchs endothelial corneal dystrophy | History, slit-lamp examination, tomography, specular microscopy, and pachymetry establish whether cornea or cataract predominates. [23] | Choose cataract surgery alone, staged DMEK and cataract surgery, or a combined procedure. [23] |

## Use targeted medical evaluation rather than routine testing

Cataract extraction is generally a low-risk ambulatory procedure, but unstable disease should be corrected before surgery.

Obtain a focused history and examination directed at conditions that can impair cooperation, anesthesia safety, perioperative hemodynamic control, or postoperative recovery. Assess the patient’s ability to cooperate during surgery and postoperative care; test and record blood pressure and blood glucose, and tailor further medical or laboratory evaluation to symptoms, medical conditions, and the planned anesthetic approach. [15]

Defer elective surgery for active infection and treat or stabilize uncontrolled systemic conditions, including high blood glucose, coronary heart disease, and severe hypertension, before proceeding. Medication review close to surgery should focus on agents that materially affect operative safety or healing. [15]

Avoid reflexive preoperative laboratory panels, electrocardiography, or universal medical consultation in asymptomatic patients undergoing routine cataract surgery. In a cohort of 968 patients, outpatient preoperative evaluation was associated with less perioperative hypertension after adjustment but did not reduce posterior capsule rupture or emergency visits or hospitalization within 7 days; no major perioperative cardiovascular events occurred. [1][17] A broader editorial assessment likewise concludes that routine medical testing has not improved patient medical outcomes in cataract surgery. [16]
- Escalate medical assessment when symptoms or known disease suggest an unstable cardiopulmonary, infectious, metabolic, or neurologic condition relevant to the planned procedure. [15]
- Do not substitute a normal routine test panel for assessment of whether the patient can cooperate with surgery and postoperative treatment. [15]
- Treat detected severe hypertension or uncontrolled diabetes as a clinical stabilization problem, not as an automatic indication for indiscriminate testing. [15]

*Targeted preoperative approach for cataract surgery. [1][15][16][17]*

| Preoperative finding | Action | Rationale |
| --- | --- | --- |
| Active infection | Treat before elective cataract surgery. [15] | Active infection should be managed before proceeding. [15] |
| Uncontrolled high blood glucose, coronary heart disease, or severe hypertension | Stabilize the systemic condition before surgery. [15] | Uncontrolled systemic disease may increase intraoperative and postoperative risk. [15] |
| Asymptomatic patient having routine low-risk cataract surgery | Do not order routine medical testing solely because cataract surgery is planned. [16] | Routine testing has not shown improvement in patient medical outcomes. [16] |
| Clinical symptoms or medical condition relevant to anesthesia or surgery | Order condition-directed testing or obtain targeted medical evaluation. [15] | Investigations should be based on patient status, symptoms, and medical conditions. [15] |

## Prioritize antisepsis and manage procedure-specific risk

Endophthalmitis prevention relies on ocular-surface antisepsis and intraoperative prophylaxis decisions.

Use povidone-iodine 5% for conjunctival-sac instillation and periorbital preparation. In a prospective study of 50 phacoemulsification patients receiving no topical antibiotic, eyelid-margin bacterial isolation declined from 96% before antisepsis to 56% afterward, with a statistically significant reduction. [10]

Routine preoperative topical antibiotic prophylaxis has no clear demonstrated benefit in cataract surgery and may promote bacterial resistance; complete eradication of ocular-surface bacteria is not achieved with this approach. [9] The cited European guidance recommends intracameral cefuroxime 1 mg at the close of surgery, and multiple studies summarized in the same report found a significant reduction in postoperative endophthalmitis with this practice. [9]

Counsel patients that posterior capsule rupture and vitreous loss are important intraoperative complications with implications for visual outcome and downstream retinal risk. Procedure planning should account for factors that make capsulotomy, nuclear fragmentation, endothelial preservation, or intraocular lens positioning more challenging; femtosecond assistance may reduce cumulative dissipated energy but does not eliminate complication risk. [11][12]
- Use antisepsis rather than routine preoperative topical antibiotics as the foundational ocular-surface infection-prevention intervention. [9][10]
- If intracameral cefuroxime is used, the dose cited in guideline-based practice is 1 mg at the end of surgery. [9]
- Document postoperative warning symptoms and ensure a pathway for urgent assessment of unexpected pain or visual decline because endophthalmitis and retinal complications are time-sensitive diagnoses. [11]

*Perioperative infection-prevention choices in cataract surgery. [9][10]*

| Intervention | Evidence-supported use | Key limitation or implementation point |
| --- | --- | --- |
| Povidone-iodine 5% | Instill in the conjunctival sac and use for periorbital scrub before phacoemulsification. [10] | Reduces eyelid-margin bacterial recovery but does not guarantee a sterile anterior chamber. [10] |
| Routine preoperative topical antibiotics | No clear benefit is demonstrated for routine use. [9] | May induce bacterial resistance and does not completely eradicate ocular-surface bacteria. [9] |
| Intracameral cefuroxime | Guideline-based regimen cited is 1 mg at the close of surgery. [9] | Reported studies summarized in the source associate its use with significantly reduced postoperative endophthalmitis. [9] |

## Monitor visual recovery, refraction, and complication signals

Postoperative follow-up should verify visual function and detect complications requiring prompt treatment.

At postoperative visits, measure visual acuity and perform slit-lamp evaluation to assess visual recovery and identify postoperative abnormalities. A follow-up visit at 4 to 6 weeks is recommended in practice guidelines to evaluate visual acuity and address the need for refraction. [15][24]

Modify the follow-up plan when the intraoperative course, ocular comorbidity, or postoperative examination indicates increased risk. In Fuchs endothelial corneal dystrophy, monitor corneal status after cataract surgery because the preoperative corneal reserve and the relative contribution of endothelial disease determine whether subsequent endothelial keratoplasty is needed. [23]

Treat unexpected visual deterioration as a diagnostic trigger rather than routine recovery. The postoperative differential includes intraocular pressure elevation, cystoid macular edema, retinal detachment, posterior capsular opacification, and infectious endophthalmitis; examination should be directed by timing, symptoms, and anterior- and posterior-segment findings. [11][14]
- Schedule a 4- to 6-week assessment for acuity measurement and refractive planning when recovery is uncomplicated. [15]
- Use earlier or additional review when corneal disease, intraoperative complication, or postoperative findings alter the expected recovery pathway. [11][23]
- For uveitis-associated cataract, recognize that posterior capsular opacification may require Nd:YAG capsulotomy and that reported post-capsulotomy complications included uveitis flare, cystoid macular edema, and retinal detachment. [14]

*Postoperative surveillance targets. [11][14][15][23][24]*

| Follow-up target | Assessment | Action implication |
| --- | --- | --- |
| Visual recovery and refractive need | Measure visual acuity; assess refraction at the 4- to 6-week follow-up. [15][24] | Prescribe or update refractive correction when indicated. [15] |
| Corneal recovery in Fuchs endothelial corneal dystrophy | Reassess corneal findings and the relative effect of endothelial disease on vision. [23] | Consider whether endothelial keratoplasty is required after cataract extraction. [23] |
| Unexpected pain or declining vision | Perform urgent examination directed at infectious, pressure-related, macular, retinal, and capsular complications. [11][14] | Do not classify new deterioration as routine postoperative recovery without examination. [11] |

## References
1. The impact of preoperative evaluation on perioperative events in patients undergoing cataract surgery: a cohort study | Eye — www.nature.com — https://www.nature.com/articles/eye2016203
2. Screening for Impaired Visual Acuity in Older Adults — www.acpjournals.org — https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-151-1-200907070-00007
3. Clinical outcomes of presbyopia-correcting intraocular ... — www.nature.com — https://www.nature.com/articles/s41598-023-27830-x
4. Visual outcomes and patient satisfaction after implantations ... — www.nature.com — https://www.nature.com/articles/s41598-024-58653-z
5. Cost-benefit analysis of a trifocal intraocular lens versus a monofocal intraocular lens in South Korea — www.nature.com — https://www.nature.com/articles/s41598-025-00712-0
6. Documentation Patterns before Cataract Surgery at Ten Academic Centers - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0161642096305253
7. The Changing Pattern of Cataract Surgery Indications: A 5-Year Study of 2 Cataract Surgery Databases - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0161642014006915
8. Construction of Preoperative Assessment Program for Day Surgery in Geriatric Cataract Patients: An Evidence-Based Delphi Study - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1089947224003861
9. Standard preoperative topical antibiotics do not... : Journal of Cataract & Refractive Surgery — journals.lww.com — https://journals.lww.com/jcrs/fulltext/2017/06000/standard_preoperative_topical_antibiotics_do_not.33.aspx
10. Preoperative Antisepsis With Povidone-Iodine 5% in Cataract Surgery - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2162098923008526
11. Complications of cataract surgery - Chan - 2010 - Clinical and Experimental Optometry - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/j.1444-0938.2010.00516.x
12. Clinical outcomes of femtosecond laser–assisted cataract... : Indian Journal of Ophthalmology — journals.lww.com — https://journals.lww.com/ijo/fulltext/2022/12000/clinical_outcomes_of_femtosecond_laser_assisted.42.aspx
13. Effect of corrected distance visual acuity on intraocular lens ... — journals.lww.com — https://journals.lww.com/jcrs/fulltext/2012/10000/effect_of_corrected_distance_visual_acuity_on.26.aspx
14. Journal of Cataract & Refractive Surgery — journals.lww.com — https://journals.lww.com/jcrs/pages/default.aspx
15. Summary of recommendations for quality of care in cataract ... — iris.who.int — https://iris.who.int/server/api/core/bitstreams/aae68efc-1e9f-4e23-8eb0-654c59841466/content
16. Preoperative Medical Evaluation for Cataract Surgery: Finally an Opportunity for Common Medical Sense to Prevail - Ophthalmology — www.aaojournal.org — https://www.aaojournal.org/article/S0161-6420(20)31017-4/fulltext
17. The impact of preoperative evaluation on perioperative events in patients undergoing cataract surgery: a cohort study - PubMed — www.ncbi.nlm.nih.gov — http://www.ncbi.nlm.nih.gov/pubmed/27636228
18. A Virtual Cataract Surgery Course for Ophthalmologists ... - IOVS — iovs.arvojournals.org — https://iovs.arvojournals.org/article.aspx?articleid=2151610
19. Systematic review of needs for medical devices for ageing ... — iris.who.int — https://iris.who.int/server/api/core/bitstreams/4bc8995b-a828-4178-8411-b284ca382ff0/content
20. Elevated Inflammatory Cytokines Persist in the Aqueous ... — iovs.arvojournals.org — https://iovs.arvojournals.org/arvo/content_public/journal/iovs/938709/i1552-5783-66-4-12_1743677286.72971.pdf?resultclick=1
21. Package of Eye Care Interventions - IRIS — iris.who.int — https://iris.who.int/bitstreams/a7cc580f-d36d-4985-997d-2526279285b5/download
22. World report on vision - IRIS — iris.who.int — https://iris.who.int/bitstreams/a1406549-82eb-468b-a5a7-1c30a233eb2f/download
23. Fuchs Dystrophy and Cataract: Diagnosis, Evaluation and Treatment — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10011243
24. Cataract - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK539699

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.